Dr. Robert Rosenson, MD

• Cardiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Chicago

  Fellowship Hospital

• Brigham And Womens Hospital

  Residency Hospital, 1986

• Brigham And Womens Hospital

  Internship Hospital, 1984

• Tulane University Of Louisiana

  Medical School, 1983

• Cerebral artery signal intensity gradient from Time-of-Flight Magnetic Resonance Angiography and clinical outcome in lenticulostriate infarction: a retrospective cohort study, 2023-09-20

• Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results fromGetting to an imprOvedUnderstanding ofLow-Density lipoprotein cholesterol and dyslipidemia management (GOULD), 2022-09-19

• PCSK9 variants, LDL-cholesterol, and neurocognitive impairment: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study, 2017-11-16

• Long-term levels of LDL-C and cognitive function: The CARDIA Study, 2021-02-10

• Low density lipoprotein cholesterol response after statin initiation among persons living with HIV, 2018-03-29

• Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia, 2016-05-30

• Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits, 2023-03-29

• Association of Lipoprotein-associated Phospholipase A2and risk of incident atrial fibrillation: Findings from three cohorts, 2017-12-05

• Lipoprotein-Associated Phospholipase A2and Risk of Incident Cardiovascular Disease in a Multi-Ethnic Cohort: The Multi Ethnic Study of Atherosclerosis, 2015-05-16

• Risk for ischemic stroke and coronary heart disease associated with migraine and migraine medication among older adults, 2021-10-13

• Effect of Colesevelam HCl Monotherapy on Lipid Particles in Type 2 Diabetes Mellitus, 2014-04-08

• Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease, 2019-04-30

• Alcohol Consumption and Cardiovascular Health, 2022-05-14

• PCSK9Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data from Nine Studies of African Americans and Whites, 2017-11-22

• One-year Statin Persistence and Adherence in Adults with HIV in the United States, 2020-11-11

• A new phenotypic classification system for dyslipidemias based on the standard lipid panel, 2021-11-27

• Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects, 2012-10-16

• Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline, 2022-08-27

• Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON, 2021-04-30

• New Therapies for Lowering Triglyceride-Rich Lipoproteins JACCFocus Seminar 3/4, 2021-11-02

• Willingness to be Re-initiated on a Statin (From the REasons for Geographic And Racial Differences in Stroke [REGARDS] Study), 2018-06-02

• Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study, 2019-04-05

• The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability, 2017-04-18

• Secular Changes in Rates of Coronary Heart Disease, Fatal Coronary Heart Disease, and Out-of-Hospital Fatal Coronary Heart Disease, 2014-04-13

• Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials, 2018-04-07

• Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies, 2015-12-09

• Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study, 2023-05-05

• Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease, 2021-03-01

• Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia, 2022-12-25

• Evaluating a simple approach to identify adults meeting the 2018 AHA/ACC cholesterol guideline definition of very high risk for atherosclerotic cardiovascular disease, 2021-03-04

• Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial, 2012-05-24

• Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients, 2021-11-18

• RE: Praluent (Alirocumab)-Induced Renal Injury, 2017-10-03

• Association of blood viscosity and device-free days among hospitalized patients with COVID-19, 2023-05-02

• Shear rate specific blood viscosity and shear stress of carotid artery duplex ultrasonography in patients with lacunar infarction, 2013-04-18

• Systematic Review: Evaluating the Effect of Lipid-Lowering Therapy on Lipoprotein and Lipid Values, 2013-07-28

• Statin non-adherence: clinical consequences and proposed solutions [version 1; referees: 2 approved], 2016-04-21

• Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport, 2012-04-17

• Characteristics and cardiovascular disease event rates among African Americans and whites who meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) trial inclusion criteria, 2019-12-07

• Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial, 2023-03-06

• Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries, 2017-05-03

• Trends in the Prevalence, Awareness, Treatment and Control of High Low Density Lipoprotein-Cholesterol among US Adults from 1999-2000 through 2009-2010, 2013-05-29

• PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, 2019-02-06

• Primary Care Physician Perspectives on Barriers to Statin Treatment, 2019-12-20

• Declines in Coronary Heart Disease Incidence and Mortality among Middle-Aged Adults with and without Diabetes, 2014-05-22